Related Experiment Video
Updated: Jun 5, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
A real-world disproportionality analysis of colchicine: data mining of the public version of FDA Adverse Event
Ye Xu1, Zhilie Dai1, Guowei Tian1
1Department of Cardiology, Intervention Cardiology Center, Wuhan No.1 Hospital, Wuhan, China.
Background:
Colchicine is widely used for gout and familial Mediterranean fever (FMF) and has cardiovascular benefits. However, it is linked to various adverse drug reactions (ADRs). This study aimed to analyze colchicine-related ADRs using FAERS data for safer clinical use.
Research Design And Methods:
FAERS data from April 2005 to March 2024 were analyzed using ROR, PRR, BCPNN, and EBGM algorithms. ADRs were categorized by System Organ Classes (SOCs) and Preferred Terms (PTs).
Results:
A total of 2,435 colchicine-related ADRs were identified. The most significant SOCs were Injury, poisoning, and procedural complications (n = 1,197, EBGM05 = 6.59) and Gastrointestinal disorders (n = 817, EBGM05 = 7.34). At the PT level, notable ADRs included Neuromyopathy (n = 27, EBGM05 = 153.12), Toxic cardiomyopathy (n = 8, EBGM05 = 138.58), and Spur cell anemia (n = 3, EBGM05 = 88.06). New signals at the PT level, including Necrotizing myositis (n = 6, EBGM05 = 31.22) and Septic arthritis staphylococcal (n = 3, EBGM05 = 28.94), were detected.
Conclusions:
Continuous monitoring is essential to detect established and emerging ADRs. These findings enhance understanding of colchicine's safety profile, with further research needed to validate these signals.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Drug Response: Overview
Time Course of Drug Effect

